All Type of News
‘Invossa’ acquires product approval, but still have challenges for health insurance benefits
While Invossa K Inj has acquired approval from the Ministry of Food and Drug Safety(MFDS), it will become another challenge for the company to be qualified for the health insurance benefits.
On the 12th, the Ministry...
Blue House appoints Young-Jin Ryu, former chairman of Busan Pharmaceutical Association, as Minister of Food and Drug Safety
Young-Jin Ryu, a former chairman of the Busan Pharmaceutical Association, was appointed as the Jae-In Moon administration’s first Minister of Food and Drug Safety.
President Jae-In Moon appointed Mr. Young-Jin Ryu, a...
Jeil Pharmaceutical acquires European EDQM approval for ‘cephalosporin’ ingredientJeil Pharmaceutical(CEO/President Suk-Jae Sung) announced ‘cefpodoxime’ manufactured at the Baekam Factory’s ‘cephalosporin’ manufacturing facility located in Cheoin-gu, Yongin-...
|
Rep. Chan-Yeol Lee carries out ‘obligation of national vaccination for cervical cancer’
A bill will be prepared to add human papillomavirus causing cervical cancer and rotavirus causing gastroenteritis into the 2nd infectious disease group for the national vaccination program.
People’s Party Rep. Chan-Y...
Soom-to-be-expired medicines are also distributed due to manufacturing suspension
It was observed pharmaceutical products soon to be expired have been distributed to the market as pharmaceutical companies have continuously caused temporary out-of-stock and manufacturing suspension. Thus, returning ...
Dong-A Socio Holdings first adopts blind recruiting method in pharma industryIn order to spread the fair recruiting culture focusing on abilities without any prejudice, Dong-A Socio Group will lead the way.
Dong-A Socio Holdings(CEO/President Jong-Hyun ...
|
Hanmi Pharm far ahead of other pharmas in medicine manufacturingIt was observed Hanmi Pharm has been far ahead of others in the 1st position in medicine manufacturing performance since 2014.
According to the current state of medicine manufa...
|
Major pharmas show high interests in DGMIF’s ‘innovative renal cancer treatment technology’
The Daegu-Gyeongbuk Medical Innovation Foundation(Chairman Jae-Tae Lee, DGMIF) have drawn huge interests of major Korean and multinational pharmaceutical companies with the ‘innovative renal cancer treatment’ at the ‘...
GSK carries out promotions of personnel to director-level positions in medicine and consumer health business
In order to have continuous growth and accelerate R&D innovation in the medicine, vaccine and consumer healthcare businesses, GSK promoted personnel in a director-level position.
The Korean branch of GSK, which leads...
SFT strongly denounce pharmaceutical companies’ illegal rebates
The Society for the Future of Pharmacists(SFP) pointed out Dong-A Pharm’s illegal rebates, announcing a statement of denunciation about rebate activities of pharmaceutical companies.
Dong-A Pharm was prosecuted for p...
